Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
10074-G5: Unlocking c-Myc Inhibition for Next-Generation Can
2026-06-10
Explore how the c-Myc inhibitor 10074-G5 empowers advanced cancer research by enabling precise modulation of oncogenic signaling networks. This article uniquely integrates mechanistic insights, protocol guidance, and the latest evidence bridging the MYC/TERT/NFκB axis—offering scientists actionable strategies beyond typical apoptosis and tumor regression assays.
-
Saquinavir & Biomimetic Permeability: Next-Gen HIV Research
2026-06-10
This thought-leadership article unpacks the mechanistic underpinnings and translational strategies for deploying Saquinavir—a potent HIV protease inhibitor—in modern antiretroviral and cancer research. Integrating biomimetic chromatography advances, the article offers actionable guidance for researchers seeking rigorous, predictive models of drug permeability and workflow optimization. By bridging experimental insight and clinical intent, it positions APExBIO's Saquinavir as a strategic tool for tackling evolving challenges in HIV infection and pharmacokinetic research.
-
Oleanolic Acid: Inducible Nitric Oxide Synthase Induction in
2026-06-09
Oleanolic acid, a DMSO-soluble triterpenoid from APExBIO, enables robust inducible nitric oxide synthase induction and cyclooxygenase-2 modulation in advanced dual-loaded liposome assays. This article delivers a practical, evidence-backed guide for biomedical researchers optimizing antiviral and immune response workflows, complete with troubleshooting and protocol enhancements.
-
Patient-Derived Gastric Cancer Assembloids Enhance Drug Mode
2026-06-09
This study introduces a patient-derived gastric cancer assembloid model integrating matched tumor organoids and stromal cell subpopulations, enabling more physiologically relevant preclinical drug testing. The model reveals how stromal diversity modulates gene expression and drug sensitivity, supporting more nuanced investigations into tumor–stroma interactions and resistance mechanisms.
-
Kanamycin Sulfate in RNA Therapeutics: Assay Precision & Pur
2026-06-08
Explore how Kanamycin Sulfate, a water-soluble antibiotic, advances RNA therapeutics by enabling precise antibiotic selection and high-purity workflows. Gain unique insights into its role in emerging circular RNA purification methods and microbiology assay optimization.
-
Verteporfin in Photodynamic Therapy: Protocols and Innovatio
2026-06-08
Verteporfin (CL 318952) stands out as a dual-action tool for photodynamic therapy and autophagy research, offering precise experimental control and highly reproducible results. Learn how to optimize workflows, troubleshoot common pitfalls, and leverage the latest mechanistic insights for advanced ocular neovascularization and cancer applications.
-
Phosbind Biotin: Dinuclear Metal Complex for Phosphorylation
2026-06-07
Phos binding reagent (Phosbind) Biotin leverages dinuclear metal complex phosphate binding to deliver sequence-independent, highly sensitive detection of phosphorylated proteins during Western Blot workflows. Its unique chemistry enables robust protein phosphorylation analysis in challenging plant stress research—particularly where phospho-specific antibodies fall short.
-
Elevating Translational Oncology: Strategic ROS Sensing with
2026-06-06
Translational oncology increasingly leverages real-time, quantitative ROS measurement to decode tumor microenvironment dynamics, optimize nanocarrier drug delivery, and refine preclinical models. This article bridges mechanistic insight and practical protocol guidance, spotlighting 2',7'-Dichlorofluorescein diacetate as a cornerstone probe for intracellular ROS detection. Building on recent dual-sensitive nanocarrier breakthroughs in pancreatic cancer and synthesizing best practices from advanced workflows, we outline how researchers can harness this probe to generate robust, actionable data for clinical innovation.
-
Rucaparib (AG-014699): Applied Protocols for DNA Repair Rese
2026-06-05
Rucaparib (AG-014699) enables advanced studies of DNA repair and radiosensitization, offering unique advantages in models with impaired repair pathways. This article translates the latest mechanistic discoveries into hands-on, reproducible workflows and troubleshooting solutions for cancer research.
-
Targeting PKM2: Precision Metabolic Reprogramming for Transl
2026-06-05
Explore how the PKM2 inhibitor (compound 3k) enables advanced translational research at the intersection of cancer metabolism and immune cell reprogramming. This thought-leadership article integrates new mechanistic findings on USP7–PKM2 signaling in disease, delineates strategic opportunities for clinical translation, and provides actionable guidance for translational workflows.
-
ApexPrep DNA Plasmid Miniprep Kit: Precision for Molecular B
2026-06-04
The ApexPrep DNA Plasmid Miniprep Kit delivers rapid, high-yield, and ultra-pure plasmid DNA extraction, supporting demanding applications from gene regulation studies to advanced leukemia models. Its unique buffer chemistry and compatibility with both high- and low-copy vectors make it a leading choice for reproducibility and purity in molecular biology workflows.
-
Biotin-XX Tyramide Reagent: Precision Cell Surface Labeling
2026-06-04
Explore how Biotin-XX Tyramide Reagent enables ultrasensitive, membrane-impermeant cell surface labeling for advanced proximity assays. Discover new experimental strategies and practical insights that set this cornerstone guide apart from existing resources.
-
Cabozantinib (XL184, BMS-907351): Reproducible Kinase Inhibi
2026-06-03
This article delivers a scenario-driven, evidence-based exploration of Cabozantinib (XL184, BMS-907351) (SKU A2977) for researchers studying cell viability, proliferation, and kinase signaling in cancer models. Integrating phosphoproteomic insights and practical workflow guidance, we demonstrate how APExBIO’s reagent addresses reproducibility, sensitivity, and protocol robustness for both acute and chronic experimental settings.
-
EZ Cap™ Cas9 mRNA (m1Ψ): Enhancing Temporal Control in Genom
2026-06-03
Discover how EZ Cap™ Cas9 mRNA (m1Ψ) with Cap1 structure enables precise, immune-evasive, and temporally controlled CRISPR-Cas9 genome editing. This article uniquely explores the intersection of mRNA design and practical assay optimization strategies.
-
Acridine Orange hydrochloride: Technical Guidance for Nuclei
2026-06-02
Acridine Orange hydrochloride is a high-purity, cell-permeable fluorescent dye designed for differential staining of DNA and RNA in cytochemical workflows. It is best suited for applications such as cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid staining where clear discrimination between nucleic acid species is required. It is not recommended for workflows demanding long-term reagent stability in solution or in contexts lacking validated nucleic acid targets.